Pharmacokinetics of Oral Acyclovir in Neonates and in Infants: a Population Analysis

Por Tod, M., Lokiec, F., Bidault, R., De Bony, F., Petitjean, O., Aujard, Y.
Publicado em 2001

Penetration of ceftriaxone (1 or 2 grams intravenously) into mediastinal and cardiac tissues in humans.

Por Martin, C, Viviand, X, Alaya, M, Lokiec, F, Ennabli, K, Said, R, Pecking, M
Publicado em 1996

Effects of diclofenac on ceftriaxone pharmacokinetics in humans.

Por Merle-Melet, M, Bresler, L, Lokiec, F, Dopff, C, Boissel, P, Dureux, J B
Publicado em 1992

Pharmacokinetics and tissue penetration of a single dose of ceftriaxone (1,000 milligrams intravenously) for antibiotic prophylaxis in thoracic surgery.

Por Martin, C, Ragni, J, Lokiec, F, Guillen, J C, Auge, A, Pecking, M, Gouin, F
Publicado em 1992

Ceftriaxone diffusion from blood to aqueous humour in man.

Por Gobeaux, D, Ambart, L, Couderc, J L, Renard, P H, De Charnace, B, Lokiec, F
Publicado em 1989

Concentrations of ceftriaxone in cerebrospinal fluid of children with meningitis receiving dexamethasone therapy.

Por Gaillard, J L, Abadie, V, Cheron, G, Lacaille, F, Mahut, B, Silly, C, Matha, V, Coustere, C, Lokiec, F
Publicado em 1994

Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cells

Por Benhadji, K A, Serova, M, Ghoul, A, Cvitkovic, E, Le Tourneau, C, Ogbourne, S M, Lokiec, F, Calvo, F, Hammel, P, Faivre, S, Raymond, E
Publicado em 2008

Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients

Por Fajac, A, Gligorov, J, Rezai, K, Lévy, P, Lévy, E, Selle, F, Beerblock, K, Avenin, D, Saintigny, P, Hugonin, S, Bernaudin, J-F, Lokiec, F
Publicado em 2010

Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2

Por Brain, E, Isambert, N, Dalenc, F, Diéras, V, Bonneterre, J, Rezai, K, Jimenez, M, Mefti-Lacheraf, F, Cottura, E, Tresca, P, Vanlemmens, L, Mahier-Aït Oukhatar, C, Lokiec, F, Fumoleau, P
Publicado em 2012

A phase I clinical and pharmacokinetic study of capecitabine (Xeloda®) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours

Por Delord, J P, Pierga, J Y, Dieras, V, Bertheault-Cvitkovic, F, Turpin, F L, Lokiec, F, Lochon, I, Chatelut, E, Canal, P, Guimbaud, R, Mery-Mignard, D, Cornen, X, Mouri, Z, Bugat, R
Publicado em 2005